FNDC5 and metabolic dysfunction-associated steatotic liver disease: Irisin activates hepatic autophagy, reduces liver inflammation, promotes the browning of white adipocytes, reverses intestinal epithelial barrier dysfunction, induces mitochondrial function, and improves the NAFLD phenotype [52,53,54,55,56,57,58,59,60,61].